Skip to content

REFAColumbia Research Enhanced International Equity ETF

Grow my moneyRanked #2,993 of 2,998 in this goal

Seeks investment results that closely correspond to the performance of the Beta Advantage ® Research Enhanced International Equity Index.

Annual Cost

#5,861 of 5,861 · expensive

Fund Size

#5,861 of 5,861 · small

Return (1Y)Goal

-3.1%

Track Record

#5,861 of 5,861 · young

Performance

Total-return NAV · USD
Growth of $10,000
$11,349+13.5%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Cap

Multi cap

Strategy

Index enhanced

Factor

Quality

Index tracked

Beta Advantage Research Enhanced International Equity Index

What it actually holds

By weight

Concentration

Top 10 holdings = 27.5% of fundwell diversified

ASML Holding NV
5.0%
Novartis AG
3.5%
Roche Holding AG
3.3%
BHP Group Ltd
3.1%
Shell PLC
2.4%
AstraZeneca PLC
2.2%
Hitachi Ltd
2.2%
Sony Group Corp
2.1%
Mitsubishi Corp
1.9%
Deutsche Telekom AG
1.8%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
25.3%High

Year-on-year price swings

Max drawdown
-27.5%Moderate

Worst peak-to-trough loss

Sharpe (3Y)
-0.24Below average
Sortino (3Y)
-0.29Moderate downside risk

Listing

Exchange
NYSE Arca, Cboe BZX

Full fund details

Objective
Seeks investment results that closely correspond to the performance of the Beta Advantage ® Research Enhanced International Equity Index.
Strategy
Invests primarily in equity securities of companies located in international developed market countries, focusing on developed market large- and mid-cap growth and value companies. The Fund seeks to track the Beta Advantage ® Research Enhanced International Equity Index using a representative sampling strategy, with a concentration in the financials and industrials sectors.

What's next?

You've looked at REFA. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

Data updated on 2026-08-04